nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—CA2—osteoporosis	0.418	1	CbGaD
Indapamide—CA12—Zoledronate—osteoporosis	0.149	0.426	CbGbCtD
Indapamide—CA2—Zoledronate—osteoporosis	0.12	0.344	CbGbCtD
Indapamide—CYP3A4—Estropipate—osteoporosis	0.0145	0.0416	CbGbCtD
Indapamide—CYP3A4—Calcitriol—osteoporosis	0.0145	0.0416	CbGbCtD
Indapamide—CYP3A4—Ergocalciferol—osteoporosis	0.0116	0.0333	CbGbCtD
Indapamide—CYP3A4—Raloxifene—osteoporosis	0.00968	0.0278	CbGbCtD
Indapamide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00935	0.0268	CbGbCtD
Indapamide—CYP3A4—Cholecalciferol—osteoporosis	0.00747	0.0214	CbGbCtD
Indapamide—CYP3A4—Conjugated Estrogens—osteoporosis	0.00686	0.0197	CbGbCtD
Indapamide—CYP3A4—Estradiol—osteoporosis	0.00602	0.0173	CbGbCtD
Indapamide—CA5A—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.00536	0.0975	CbGpPWpGaD
Indapamide—CA7—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.005	0.0911	CbGpPWpGaD
Indapamide—CA5B—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.005	0.0911	CbGpPWpGaD
Indapamide—CA4—Erythrocytes take up carbon dioxide and release oxygen—CA2—osteoporosis	0.00465	0.0847	CbGpPWpGaD
Indapamide—CA12—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.00463	0.0844	CbGpPWpGaD
Indapamide—KCNE1—TarBasePathway—IGF1—osteoporosis	0.00448	0.0816	CbGpPWpGaD
Indapamide—CA4—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.0037	0.0673	CbGpPWpGaD
Indapamide—CA9—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.00299	0.0544	CbGpPWpGaD
Indapamide—Furosemide—CA2—osteoporosis	0.00146	0.574	CrCbGaD
Indapamide—KCNQ1—TarBasePathway—IGF1—osteoporosis	0.00135	0.0246	CbGpPWpGaD
Indapamide—Chlorthalidone—CA2—osteoporosis	0.00109	0.426	CrCbGaD
Indapamide—CA9—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.00104	0.0189	CbGpPWpGaD
Indapamide—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000852	0.0155	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.00054	0.00983	CbGpPWpGaD
Indapamide—CA9—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.000391	0.00712	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000374	0.00682	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—PRDX3—osteoporosis	0.000324	0.0059	CbGpPWpGaD
Indapamide—CA9—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.000219	0.00398	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000199	0.00363	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—ADCY5—osteoporosis	0.000174	0.00318	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—P4HB—osteoporosis	0.000167	0.00304	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000166	0.00302	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000152	0.00276	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PKM—osteoporosis	0.000148	0.00269	CbGpPWpGaD
Indapamide—CA5A—Metabolism—FDPS—osteoporosis	0.000148	0.00269	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PGLS—osteoporosis	0.00014	0.00255	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GPD2—osteoporosis	0.00014	0.00255	CbGpPWpGaD
Indapamide—CA7—Metabolism—PKM—osteoporosis	0.000138	0.00251	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PKM—osteoporosis	0.000138	0.00251	CbGpPWpGaD
Indapamide—CA7—Metabolism—FDPS—osteoporosis	0.000138	0.00251	CbGpPWpGaD
Indapamide—CA5B—Metabolism—FDPS—osteoporosis	0.000138	0.00251	CbGpPWpGaD
Indapamide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000136	0.00248	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GPD2—osteoporosis	0.000131	0.00238	CbGpPWpGaD
Indapamide—CA7—Metabolism—PGLS—osteoporosis	0.000131	0.00238	CbGpPWpGaD
Indapamide—CA7—Metabolism—GPD2—osteoporosis	0.000131	0.00238	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PGLS—osteoporosis	0.000131	0.00238	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ATIC—osteoporosis	0.000128	0.00233	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PNP—osteoporosis	0.000128	0.00233	CbGpPWpGaD
Indapamide—CA12—Metabolism—FDPS—osteoporosis	0.000128	0.00233	CbGpPWpGaD
Indapamide—CA12—Metabolism—PKM—osteoporosis	0.000128	0.00233	CbGpPWpGaD
Indapamide—CA12—Metabolism—PGLS—osteoporosis	0.000121	0.0022	CbGpPWpGaD
Indapamide—CA12—Metabolism—GPD2—osteoporosis	0.000121	0.0022	CbGpPWpGaD
Indapamide—CA7—Metabolism—PNP—osteoporosis	0.00012	0.00218	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PNP—osteoporosis	0.00012	0.00218	CbGpPWpGaD
Indapamide—CA7—Metabolism—ATIC—osteoporosis	0.00012	0.00218	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ATIC—osteoporosis	0.00012	0.00218	CbGpPWpGaD
Indapamide—CA12—Metabolism—PNP—osteoporosis	0.000111	0.00202	CbGpPWpGaD
Indapamide—CA12—Metabolism—ATIC—osteoporosis	0.000111	0.00202	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—TNF—osteoporosis	0.00011	0.002	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CA2—osteoporosis	0.000109	0.00198	CbGpPWpGaD
Indapamide—CA5A—Metabolism—OXCT1—osteoporosis	0.000109	0.00198	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000108	0.00197	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000107	0.00194	CbGpPWpGaD
Indapamide—CA5A—Metabolism—MGLL—osteoporosis	0.000106	0.00193	CbGpPWpGaD
Indapamide—CA4—Metabolism—PKM—osteoporosis	0.000102	0.00185	CbGpPWpGaD
Indapamide—CA4—Metabolism—FDPS—osteoporosis	0.000102	0.00185	CbGpPWpGaD
Indapamide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000102	0.00185	CbGpPWpGaD
Indapamide—CA5B—Metabolism—OXCT1—osteoporosis	0.000102	0.00185	CbGpPWpGaD
Indapamide—CA7—Metabolism—CA2—osteoporosis	0.000102	0.00185	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CA2—osteoporosis	0.000102	0.00185	CbGpPWpGaD
Indapamide—CA7—Metabolism—OXCT1—osteoporosis	0.000102	0.00185	CbGpPWpGaD
Indapamide—CA5B—Metabolism—MGLL—osteoporosis	9.91e-05	0.0018	CbGpPWpGaD
Indapamide—CA7—Metabolism—MGLL—osteoporosis	9.91e-05	0.0018	CbGpPWpGaD
Indapamide—CA2—Metabolism—FDPS—osteoporosis	9.77e-05	0.00178	CbGpPWpGaD
Indapamide—CA2—Metabolism—PKM—osteoporosis	9.77e-05	0.00178	CbGpPWpGaD
Indapamide—CA4—Metabolism—PGLS—osteoporosis	9.66e-05	0.00176	CbGpPWpGaD
Indapamide—CA4—Metabolism—GPD2—osteoporosis	9.66e-05	0.00176	CbGpPWpGaD
Indapamide—Pruritus—Estropipate—osteoporosis	9.51e-05	0.000542	CcSEcCtD
Indapamide—Discomfort—Zoledronate—osteoporosis	9.5e-05	0.000542	CcSEcCtD
Indapamide—Asthenia—Alendronate—osteoporosis	9.5e-05	0.000541	CcSEcCtD
Indapamide—Hypersensitivity—Ibandronate—osteoporosis	9.49e-05	0.000541	CcSEcCtD
Indapamide—Cough—Conjugated Estrogens—osteoporosis	9.49e-05	0.000541	CcSEcCtD
Indapamide—Dyspnoea—Risedronate—osteoporosis	9.47e-05	0.00054	CcSEcCtD
Indapamide—Erythema multiforme—Estradiol—osteoporosis	9.46e-05	0.000539	CcSEcCtD
Indapamide—Hypotension—Pamidronate—osteoporosis	9.43e-05	0.000538	CcSEcCtD
Indapamide—CA12—Metabolism—CA2—osteoporosis	9.42e-05	0.00171	CbGpPWpGaD
Indapamide—CA12—Metabolism—OXCT1—osteoporosis	9.42e-05	0.00171	CbGpPWpGaD
Indapamide—Dry mouth—Zoledronate—osteoporosis	9.41e-05	0.000536	CcSEcCtD
Indapamide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	9.4e-05	0.000536	CcSEcCtD
Indapamide—Fatigue—Ethinyl Estradiol—osteoporosis	9.39e-05	0.000535	CcSEcCtD
Indapamide—Pruritus—Alendronate—osteoporosis	9.36e-05	0.000534	CcSEcCtD
Indapamide—Dyspepsia—Risedronate—osteoporosis	9.35e-05	0.000533	CcSEcCtD
Indapamide—Tinnitus—Estradiol—osteoporosis	9.33e-05	0.000532	CcSEcCtD
Indapamide—Constipation—Ethinyl Estradiol—osteoporosis	9.31e-05	0.000531	CcSEcCtD
Indapamide—Hypersensitivity—Calcitriol—osteoporosis	9.29e-05	0.00053	CcSEcCtD
Indapamide—Flushing—Estradiol—osteoporosis	9.28e-05	0.000529	CcSEcCtD
Indapamide—Cardiac disorder—Estradiol—osteoporosis	9.28e-05	0.000529	CcSEcCtD
Indapamide—Myalgia—Conjugated Estrogens—osteoporosis	9.26e-05	0.000528	CcSEcCtD
Indapamide—Chest pain—Conjugated Estrogens—osteoporosis	9.26e-05	0.000528	CcSEcCtD
Indapamide—Arthralgia—Conjugated Estrogens—osteoporosis	9.26e-05	0.000528	CcSEcCtD
Indapamide—CA2—Metabolism—GPD2—osteoporosis	9.26e-05	0.00169	CbGpPWpGaD
Indapamide—CA2—Metabolism—PGLS—osteoporosis	9.26e-05	0.00169	CbGpPWpGaD
Indapamide—Asthenia—Ibandronate—osteoporosis	9.25e-05	0.000527	CcSEcCtD
Indapamide—Anxiety—Conjugated Estrogens—osteoporosis	9.23e-05	0.000526	CcSEcCtD
Indapamide—Nausea—Etidronic acid—osteoporosis	9.23e-05	0.000526	CcSEcCtD
Indapamide—Anaphylactic shock—Zoledronate—osteoporosis	9.22e-05	0.000526	CcSEcCtD
Indapamide—Oedema—Zoledronate—osteoporosis	9.22e-05	0.000526	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	9.2e-05	0.000524	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Pamidronate—osteoporosis	9.2e-05	0.000524	CcSEcCtD
Indapamide—Diarrhoea—Estropipate—osteoporosis	9.19e-05	0.000524	CcSEcCtD
Indapamide—CA12—Metabolism—MGLL—osteoporosis	9.18e-05	0.00167	CbGpPWpGaD
Indapamide—Gastrointestinal disorder—Risedronate—osteoporosis	9.17e-05	0.000523	CcSEcCtD
Indapamide—Infection—Zoledronate—osteoporosis	9.16e-05	0.000522	CcSEcCtD
Indapamide—Fatigue—Risedronate—osteoporosis	9.16e-05	0.000522	CcSEcCtD
Indapamide—Insomnia—Pamidronate—osteoporosis	9.13e-05	0.00052	CcSEcCtD
Indapamide—Pruritus—Ibandronate—osteoporosis	9.12e-05	0.00052	CcSEcCtD
Indapamide—Pain—Risedronate—osteoporosis	9.08e-05	0.000518	CcSEcCtD
Indapamide—Constipation—Risedronate—osteoporosis	9.08e-05	0.000518	CcSEcCtD
Indapamide—Shock—Zoledronate—osteoporosis	9.07e-05	0.000517	CcSEcCtD
Indapamide—Paraesthesia—Pamidronate—osteoporosis	9.06e-05	0.000517	CcSEcCtD
Indapamide—Diarrhoea—Alendronate—osteoporosis	9.06e-05	0.000516	CcSEcCtD
Indapamide—Asthenia—Calcitriol—osteoporosis	9.05e-05	0.000516	CcSEcCtD
Indapamide—Nervous system disorder—Zoledronate—osteoporosis	9.04e-05	0.000515	CcSEcCtD
Indapamide—Thrombocytopenia—Zoledronate—osteoporosis	9.03e-05	0.000515	CcSEcCtD
Indapamide—CA5A—Metabolism—IDH2—osteoporosis	9.02e-05	0.00164	CbGpPWpGaD
Indapamide—Dyspnoea—Pamidronate—osteoporosis	9e-05	0.000513	CcSEcCtD
Indapamide—Tachycardia—Zoledronate—osteoporosis	9e-05	0.000513	CcSEcCtD
Indapamide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	8.98e-05	0.000512	CcSEcCtD
Indapamide—Somnolence—Pamidronate—osteoporosis	8.97e-05	0.000511	CcSEcCtD
Indapamide—Skin disorder—Zoledronate—osteoporosis	8.96e-05	0.00051	CcSEcCtD
Indapamide—Pruritus—Calcitriol—osteoporosis	8.92e-05	0.000509	CcSEcCtD
Indapamide—Hyperhidrosis—Zoledronate—osteoporosis	8.91e-05	0.000508	CcSEcCtD
Indapamide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	8.91e-05	0.000508	CcSEcCtD
Indapamide—Diarrhoea—Raloxifene—osteoporosis	8.91e-05	0.000508	CcSEcCtD
Indapamide—Dyspepsia—Pamidronate—osteoporosis	8.89e-05	0.000506	CcSEcCtD
Indapamide—Dizziness—Estropipate—osteoporosis	8.89e-05	0.000506	CcSEcCtD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—IL6—osteoporosis	8.88e-05	0.00162	CbGpPWpGaD
Indapamide—Anaphylactic shock—Conjugated Estrogens—osteoporosis	8.88e-05	0.000506	CcSEcCtD
Indapamide—Oedema—Conjugated Estrogens—osteoporosis	8.88e-05	0.000506	CcSEcCtD
Indapamide—CA4—Metabolism—PNP—osteoporosis	8.83e-05	0.00161	CbGpPWpGaD
Indapamide—CA4—Metabolism—ATIC—osteoporosis	8.83e-05	0.00161	CbGpPWpGaD
Indapamide—Infection—Conjugated Estrogens—osteoporosis	8.82e-05	0.000503	CcSEcCtD
Indapamide—Diarrhoea—Ibandronate—osteoporosis	8.82e-05	0.000502	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—SOD2—osteoporosis	8.8e-05	0.0016	CbGpPWpGaD
Indapamide—Anorexia—Zoledronate—osteoporosis	8.79e-05	0.000501	CcSEcCtD
Indapamide—Decreased appetite—Pamidronate—osteoporosis	8.78e-05	0.0005	CcSEcCtD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	8.76e-05	0.00159	CbGpPWpGaD
Indapamide—Dizziness—Alendronate—osteoporosis	8.75e-05	0.000499	CcSEcCtD
Indapamide—Shock—Conjugated Estrogens—osteoporosis	8.74e-05	0.000498	CcSEcCtD
Indapamide—Gastrointestinal disorder—Pamidronate—osteoporosis	8.72e-05	0.000497	CcSEcCtD
Indapamide—Nervous system disorder—Conjugated Estrogens—osteoporosis	8.71e-05	0.000496	CcSEcCtD
Indapamide—Erythema—Estradiol—osteoporosis	8.71e-05	0.000496	CcSEcCtD
Indapamide—Malnutrition—Estradiol—osteoporosis	8.71e-05	0.000496	CcSEcCtD
Indapamide—Fatigue—Pamidronate—osteoporosis	8.7e-05	0.000496	CcSEcCtD
Indapamide—Gastrointestinal pain—Risedronate—osteoporosis	8.68e-05	0.000495	CcSEcCtD
Indapamide—Tachycardia—Conjugated Estrogens—osteoporosis	8.67e-05	0.000494	CcSEcCtD
Indapamide—Urticaria—Ethinyl Estradiol—osteoporosis	8.65e-05	0.000493	CcSEcCtD
Indapamide—Pain—Pamidronate—osteoporosis	8.63e-05	0.000492	CcSEcCtD
Indapamide—Constipation—Pamidronate—osteoporosis	8.63e-05	0.000492	CcSEcCtD
Indapamide—Diarrhoea—Calcitriol—osteoporosis	8.63e-05	0.000492	CcSEcCtD
Indapamide—Skin disorder—Conjugated Estrogens—osteoporosis	8.62e-05	0.000492	CcSEcCtD
Indapamide—Hypotension—Zoledronate—osteoporosis	8.62e-05	0.000491	CcSEcCtD
Indapamide—Abdominal pain—Ethinyl Estradiol—osteoporosis	8.61e-05	0.000491	CcSEcCtD
Indapamide—Body temperature increased—Ethinyl Estradiol—osteoporosis	8.61e-05	0.000491	CcSEcCtD
Indapamide—Dizziness—Raloxifene—osteoporosis	8.61e-05	0.000491	CcSEcCtD
Indapamide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	8.58e-05	0.000489	CcSEcCtD
Indapamide—Flatulence—Estradiol—osteoporosis	8.58e-05	0.000489	CcSEcCtD
Indapamide—Tension—Estradiol—osteoporosis	8.54e-05	0.000487	CcSEcCtD
Indapamide—Vomiting—Estropipate—osteoporosis	8.54e-05	0.000487	CcSEcCtD
Indapamide—Dysgeusia—Estradiol—osteoporosis	8.53e-05	0.000486	CcSEcCtD
Indapamide—Dizziness—Ibandronate—osteoporosis	8.52e-05	0.000486	CcSEcCtD
Indapamide—CA5A—Metabolism—CYP27A1—osteoporosis	8.48e-05	0.00154	CbGpPWpGaD
Indapamide—Rash—Estropipate—osteoporosis	8.47e-05	0.000483	CcSEcCtD
Indapamide—CA2—Metabolism—ATIC—osteoporosis	8.47e-05	0.00154	CbGpPWpGaD
Indapamide—CA2—Metabolism—PNP—osteoporosis	8.47e-05	0.00154	CbGpPWpGaD
Indapamide—Dermatitis—Estropipate—osteoporosis	8.46e-05	0.000482	CcSEcCtD
Indapamide—Anorexia—Conjugated Estrogens—osteoporosis	8.46e-05	0.000482	CcSEcCtD
Indapamide—Nervousness—Estradiol—osteoporosis	8.46e-05	0.000482	CcSEcCtD
Indapamide—Urticaria—Risedronate—osteoporosis	8.44e-05	0.000481	CcSEcCtD
Indapamide—CA7—Metabolism—IDH2—osteoporosis	8.42e-05	0.00153	CbGpPWpGaD
Indapamide—CA5B—Metabolism—IDH2—osteoporosis	8.42e-05	0.00153	CbGpPWpGaD
Indapamide—Back pain—Estradiol—osteoporosis	8.42e-05	0.00048	CcSEcCtD
Indapamide—Headache—Estropipate—osteoporosis	8.42e-05	0.00048	CcSEcCtD
Indapamide—Vomiting—Alendronate—osteoporosis	8.42e-05	0.00048	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Zoledronate—osteoporosis	8.4e-05	0.000479	CcSEcCtD
Indapamide—Body temperature increased—Risedronate—osteoporosis	8.39e-05	0.000478	CcSEcCtD
Indapamide—Abdominal pain—Risedronate—osteoporosis	8.39e-05	0.000478	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—GPX1—osteoporosis	8.39e-05	0.00153	CbGpPWpGaD
Indapamide—Muscle spasms—Estradiol—osteoporosis	8.37e-05	0.000477	CcSEcCtD
Indapamide—Rash—Alendronate—osteoporosis	8.34e-05	0.000476	CcSEcCtD
Indapamide—Insomnia—Zoledronate—osteoporosis	8.34e-05	0.000475	CcSEcCtD
Indapamide—Dermatitis—Alendronate—osteoporosis	8.34e-05	0.000475	CcSEcCtD
Indapamide—Feeling abnormal—Pamidronate—osteoporosis	8.32e-05	0.000474	CcSEcCtD
Indapamide—Hypotension—Conjugated Estrogens—osteoporosis	8.3e-05	0.000473	CcSEcCtD
Indapamide—Headache—Alendronate—osteoporosis	8.29e-05	0.000473	CcSEcCtD
Indapamide—Paraesthesia—Zoledronate—osteoporosis	8.28e-05	0.000472	CcSEcCtD
Indapamide—Vomiting—Raloxifene—osteoporosis	8.28e-05	0.000472	CcSEcCtD
Indapamide—Gastrointestinal pain—Pamidronate—osteoporosis	8.25e-05	0.00047	CcSEcCtD
Indapamide—CA5A—Metabolism—ACP5—osteoporosis	8.25e-05	0.0015	CbGpPWpGaD
Indapamide—CA9—Metabolism—FDPS—osteoporosis	8.23e-05	0.0015	CbGpPWpGaD
Indapamide—CA9—Metabolism—PKM—osteoporosis	8.23e-05	0.0015	CbGpPWpGaD
Indapamide—Dyspnoea—Zoledronate—osteoporosis	8.22e-05	0.000469	CcSEcCtD
Indapamide—Rash—Raloxifene—osteoporosis	8.21e-05	0.000468	CcSEcCtD
Indapamide—Dermatitis—Raloxifene—osteoporosis	8.2e-05	0.000467	CcSEcCtD
Indapamide—Somnolence—Zoledronate—osteoporosis	8.2e-05	0.000467	CcSEcCtD
Indapamide—Vomiting—Ibandronate—osteoporosis	8.19e-05	0.000467	CcSEcCtD
Indapamide—Headache—Raloxifene—osteoporosis	8.15e-05	0.000465	CcSEcCtD
Indapamide—Rash—Ibandronate—osteoporosis	8.12e-05	0.000463	CcSEcCtD
Indapamide—Dermatitis—Ibandronate—osteoporosis	8.12e-05	0.000463	CcSEcCtD
Indapamide—Dyspepsia—Zoledronate—osteoporosis	8.12e-05	0.000463	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	8.09e-05	0.000461	CcSEcCtD
Indapamide—Ill-defined disorder—Estradiol—osteoporosis	8.08e-05	0.00046	CcSEcCtD
Indapamide—Headache—Ibandronate—osteoporosis	8.07e-05	0.00046	CcSEcCtD
Indapamide—Insomnia—Conjugated Estrogens—osteoporosis	8.03e-05	0.000458	CcSEcCtD
Indapamide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	8.02e-05	0.000457	CcSEcCtD
Indapamide—Vomiting—Calcitriol—osteoporosis	8.02e-05	0.000457	CcSEcCtD
Indapamide—Decreased appetite—Zoledronate—osteoporosis	8.02e-05	0.000457	CcSEcCtD
Indapamide—Agitation—Estradiol—osteoporosis	8e-05	0.000456	CcSEcCtD
Indapamide—Nausea—Estropipate—osteoporosis	7.98e-05	0.000455	CcSEcCtD
Indapamide—Body temperature increased—Pamidronate—osteoporosis	7.98e-05	0.000455	CcSEcCtD
Indapamide—Abdominal pain—Pamidronate—osteoporosis	7.98e-05	0.000455	CcSEcCtD
Indapamide—Paraesthesia—Conjugated Estrogens—osteoporosis	7.97e-05	0.000454	CcSEcCtD
Indapamide—Gastrointestinal disorder—Zoledronate—osteoporosis	7.96e-05	0.000454	CcSEcCtD
Indapamide—Angioedema—Estradiol—osteoporosis	7.96e-05	0.000453	CcSEcCtD
Indapamide—Rash—Calcitriol—osteoporosis	7.95e-05	0.000453	CcSEcCtD
Indapamide—Fatigue—Zoledronate—osteoporosis	7.95e-05	0.000453	CcSEcCtD
Indapamide—Dermatitis—Calcitriol—osteoporosis	7.95e-05	0.000453	CcSEcCtD
Indapamide—CA5B—Metabolism—CYP27A1—osteoporosis	7.92e-05	0.00144	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP27A1—osteoporosis	7.92e-05	0.00144	CbGpPWpGaD
Indapamide—Dyspnoea—Conjugated Estrogens—osteoporosis	7.92e-05	0.000451	CcSEcCtD
Indapamide—Headache—Calcitriol—osteoporosis	7.9e-05	0.00045	CcSEcCtD
Indapamide—Somnolence—Conjugated Estrogens—osteoporosis	7.89e-05	0.00045	CcSEcCtD
Indapamide—Pain—Zoledronate—osteoporosis	7.89e-05	0.000449	CcSEcCtD
Indapamide—Constipation—Zoledronate—osteoporosis	7.89e-05	0.000449	CcSEcCtD
Indapamide—Nausea—Alendronate—osteoporosis	7.86e-05	0.000448	CcSEcCtD
Indapamide—Malaise—Estradiol—osteoporosis	7.85e-05	0.000448	CcSEcCtD
Indapamide—Hypersensitivity—Risedronate—osteoporosis	7.82e-05	0.000446	CcSEcCtD
Indapamide—Vertigo—Estradiol—osteoporosis	7.82e-05	0.000446	CcSEcCtD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	7.82e-05	0.00142	CbGpPWpGaD
Indapamide—Dyspepsia—Conjugated Estrogens—osteoporosis	7.82e-05	0.000445	CcSEcCtD
Indapamide—Asthenia—Ethinyl Estradiol—osteoporosis	7.81e-05	0.000445	CcSEcCtD
Indapamide—Syncope—Estradiol—osteoporosis	7.81e-05	0.000445	CcSEcCtD
Indapamide—CA9—Metabolism—PGLS—osteoporosis	7.8e-05	0.00142	CbGpPWpGaD
Indapamide—CA9—Metabolism—GPD2—osteoporosis	7.8e-05	0.00142	CbGpPWpGaD
Indapamide—CA12—Metabolism—IDH2—osteoporosis	7.8e-05	0.00142	CbGpPWpGaD
Indapamide—Nausea—Raloxifene—osteoporosis	7.73e-05	0.000441	CcSEcCtD
Indapamide—Decreased appetite—Conjugated Estrogens—osteoporosis	7.72e-05	0.00044	CcSEcCtD
Indapamide—Pruritus—Ethinyl Estradiol—osteoporosis	7.71e-05	0.000439	CcSEcCtD
Indapamide—CA7—Metabolism—ACP5—osteoporosis	7.7e-05	0.0014	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ACP5—osteoporosis	7.7e-05	0.0014	CbGpPWpGaD
Indapamide—Palpitations—Estradiol—osteoporosis	7.69e-05	0.000439	CcSEcCtD
Indapamide—CA5A—Metabolism—TPI1—osteoporosis	7.67e-05	0.0014	CbGpPWpGaD
Indapamide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	7.67e-05	0.000437	CcSEcCtD
Indapamide—Fatigue—Conjugated Estrogens—osteoporosis	7.66e-05	0.000436	CcSEcCtD
Indapamide—Nausea—Ibandronate—osteoporosis	7.65e-05	0.000436	CcSEcCtD
Indapamide—Loss of consciousness—Estradiol—osteoporosis	7.65e-05	0.000436	CcSEcCtD
Indapamide—Asthenia—Risedronate—osteoporosis	7.62e-05	0.000434	CcSEcCtD
Indapamide—Feeling abnormal—Zoledronate—osteoporosis	7.6e-05	0.000433	CcSEcCtD
Indapamide—Cough—Estradiol—osteoporosis	7.6e-05	0.000433	CcSEcCtD
Indapamide—Constipation—Conjugated Estrogens—osteoporosis	7.59e-05	0.000433	CcSEcCtD
Indapamide—Pain—Conjugated Estrogens—osteoporosis	7.59e-05	0.000433	CcSEcCtD
Indapamide—Gastrointestinal pain—Zoledronate—osteoporosis	7.54e-05	0.00043	CcSEcCtD
Indapamide—Pruritus—Risedronate—osteoporosis	7.51e-05	0.000428	CcSEcCtD
Indapamide—CA4—Metabolism—OXCT1—osteoporosis	7.51e-05	0.00137	CbGpPWpGaD
Indapamide—CA4—Metabolism—CA2—osteoporosis	7.51e-05	0.00137	CbGpPWpGaD
Indapamide—Nausea—Calcitriol—osteoporosis	7.49e-05	0.000427	CcSEcCtD
Indapamide—Diarrhoea—Ethinyl Estradiol—osteoporosis	7.45e-05	0.000425	CcSEcCtD
Indapamide—Hypersensitivity—Pamidronate—osteoporosis	7.44e-05	0.000424	CcSEcCtD
Indapamide—Arthralgia—Estradiol—osteoporosis	7.41e-05	0.000422	CcSEcCtD
Indapamide—Myalgia—Estradiol—osteoporosis	7.41e-05	0.000422	CcSEcCtD
Indapamide—Chest pain—Estradiol—osteoporosis	7.41e-05	0.000422	CcSEcCtD
Indapamide—Anxiety—Estradiol—osteoporosis	7.39e-05	0.000421	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	7.36e-05	0.00042	CcSEcCtD
Indapamide—CA12—Metabolism—CYP27A1—osteoporosis	7.34e-05	0.00134	CbGpPWpGaD
Indapamide—Urticaria—Zoledronate—osteoporosis	7.33e-05	0.000418	CcSEcCtD
Indapamide—Discomfort—Estradiol—osteoporosis	7.32e-05	0.000417	CcSEcCtD
Indapamide—CA4—Metabolism—MGLL—osteoporosis	7.32e-05	0.00133	CbGpPWpGaD
Indapamide—Body temperature increased—Zoledronate—osteoporosis	7.29e-05	0.000415	CcSEcCtD
Indapamide—Abdominal pain—Zoledronate—osteoporosis	7.29e-05	0.000415	CcSEcCtD
Indapamide—Diarrhoea—Risedronate—osteoporosis	7.27e-05	0.000414	CcSEcCtD
Indapamide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	7.26e-05	0.000414	CcSEcCtD
Indapamide—Dry mouth—Estradiol—osteoporosis	7.25e-05	0.000413	CcSEcCtD
Indapamide—Asthenia—Pamidronate—osteoporosis	7.24e-05	0.000413	CcSEcCtD
Indapamide—CA5A—Metabolism—P4HB—osteoporosis	7.21e-05	0.00131	CbGpPWpGaD
Indapamide—Dizziness—Ethinyl Estradiol—osteoporosis	7.2e-05	0.000411	CcSEcCtD
Indapamide—CA2—Metabolism—OXCT1—osteoporosis	7.2e-05	0.00131	CbGpPWpGaD
Indapamide—CA7—Metabolism—TPI1—osteoporosis	7.16e-05	0.0013	CbGpPWpGaD
Indapamide—CA5B—Metabolism—TPI1—osteoporosis	7.16e-05	0.0013	CbGpPWpGaD
Indapamide—Pruritus—Pamidronate—osteoporosis	7.14e-05	0.000407	CcSEcCtD
Indapamide—CA9—Metabolism—ATIC—osteoporosis	7.14e-05	0.0013	CbGpPWpGaD
Indapamide—CA9—Metabolism—PNP—osteoporosis	7.14e-05	0.0013	CbGpPWpGaD
Indapamide—CA12—Metabolism—ACP5—osteoporosis	7.14e-05	0.0013	CbGpPWpGaD
Indapamide—Oedema—Estradiol—osteoporosis	7.11e-05	0.000405	CcSEcCtD
Indapamide—Anaphylactic shock—Estradiol—osteoporosis	7.11e-05	0.000405	CcSEcCtD
Indapamide—CA5A—Metabolism—GAPDH—osteoporosis	7.08e-05	0.00129	CbGpPWpGaD
Indapamide—Infection—Estradiol—osteoporosis	7.06e-05	0.000402	CcSEcCtD
Indapamide—Urticaria—Conjugated Estrogens—osteoporosis	7.05e-05	0.000402	CcSEcCtD
Indapamide—Dizziness—Risedronate—osteoporosis	7.02e-05	0.0004	CcSEcCtD
Indapamide—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	7.02e-05	0.00128	CbGpPWpGaD
Indapamide—Body temperature increased—Conjugated Estrogens—osteoporosis	7.02e-05	0.0004	CcSEcCtD
Indapamide—Abdominal pain—Conjugated Estrogens—osteoporosis	7.02e-05	0.0004	CcSEcCtD
Indapamide—CA2—Metabolism—MGLL—osteoporosis	7.02e-05	0.00128	CbGpPWpGaD
Indapamide—Shock—Estradiol—osteoporosis	6.99e-05	0.000398	CcSEcCtD
Indapamide—Nervous system disorder—Estradiol—osteoporosis	6.97e-05	0.000397	CcSEcCtD
Indapamide—Tachycardia—Estradiol—osteoporosis	6.94e-05	0.000395	CcSEcCtD
Indapamide—Vomiting—Ethinyl Estradiol—osteoporosis	6.93e-05	0.000395	CcSEcCtD
Indapamide—Diarrhoea—Pamidronate—osteoporosis	6.91e-05	0.000394	CcSEcCtD
Indapamide—Skin disorder—Estradiol—osteoporosis	6.9e-05	0.000393	CcSEcCtD
Indapamide—CA5A—Metabolism—RAP1A—osteoporosis	6.9e-05	0.00126	CbGpPWpGaD
Indapamide—Hyperhidrosis—Estradiol—osteoporosis	6.87e-05	0.000392	CcSEcCtD
Indapamide—Rash—Ethinyl Estradiol—osteoporosis	6.87e-05	0.000391	CcSEcCtD
Indapamide—Dermatitis—Ethinyl Estradiol—osteoporosis	6.86e-05	0.000391	CcSEcCtD
Indapamide—Headache—Ethinyl Estradiol—osteoporosis	6.82e-05	0.000389	CcSEcCtD
Indapamide—Hypersensitivity—Zoledronate—osteoporosis	6.79e-05	0.000387	CcSEcCtD
Indapamide—Vomiting—Risedronate—osteoporosis	6.75e-05	0.000385	CcSEcCtD
Indapamide—CA7—Metabolism—P4HB—osteoporosis	6.73e-05	0.00123	CbGpPWpGaD
Indapamide—CA5B—Metabolism—P4HB—osteoporosis	6.73e-05	0.00123	CbGpPWpGaD
Indapamide—Rash—Risedronate—osteoporosis	6.7e-05	0.000382	CcSEcCtD
Indapamide—Dermatitis—Risedronate—osteoporosis	6.69e-05	0.000381	CcSEcCtD
Indapamide—Dizziness—Pamidronate—osteoporosis	6.68e-05	0.00038	CcSEcCtD
Indapamide—Headache—Risedronate—osteoporosis	6.65e-05	0.000379	CcSEcCtD
Indapamide—CA12—Metabolism—TPI1—osteoporosis	6.63e-05	0.00121	CbGpPWpGaD
Indapamide—Asthenia—Zoledronate—osteoporosis	6.62e-05	0.000377	CcSEcCtD
Indapamide—CA7—Metabolism—GAPDH—osteoporosis	6.61e-05	0.0012	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GAPDH—osteoporosis	6.61e-05	0.0012	CbGpPWpGaD
Indapamide—Hypersensitivity—Conjugated Estrogens—osteoporosis	6.54e-05	0.000373	CcSEcCtD
Indapamide—Pruritus—Zoledronate—osteoporosis	6.52e-05	0.000372	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Estradiol—osteoporosis	6.47e-05	0.000369	CcSEcCtD
Indapamide—Nausea—Ethinyl Estradiol—osteoporosis	6.47e-05	0.000369	CcSEcCtD
Indapamide—CA7—Metabolism—RAP1A—osteoporosis	6.44e-05	0.00117	CbGpPWpGaD
Indapamide—CA5B—Metabolism—RAP1A—osteoporosis	6.44e-05	0.00117	CbGpPWpGaD
Indapamide—Insomnia—Estradiol—osteoporosis	6.43e-05	0.000366	CcSEcCtD
Indapamide—Vomiting—Pamidronate—osteoporosis	6.42e-05	0.000366	CcSEcCtD
Indapamide—Paraesthesia—Estradiol—osteoporosis	6.38e-05	0.000364	CcSEcCtD
Indapamide—Asthenia—Conjugated Estrogens—osteoporosis	6.37e-05	0.000363	CcSEcCtD
Indapamide—Rash—Pamidronate—osteoporosis	6.37e-05	0.000363	CcSEcCtD
Indapamide—Dermatitis—Pamidronate—osteoporosis	6.36e-05	0.000362	CcSEcCtD
Indapamide—Dyspnoea—Estradiol—osteoporosis	6.34e-05	0.000361	CcSEcCtD
Indapamide—Headache—Pamidronate—osteoporosis	6.32e-05	0.00036	CcSEcCtD
Indapamide—Somnolence—Estradiol—osteoporosis	6.32e-05	0.00036	CcSEcCtD
Indapamide—Diarrhoea—Zoledronate—osteoporosis	6.31e-05	0.00036	CcSEcCtD
Indapamide—Nausea—Risedronate—osteoporosis	6.31e-05	0.00036	CcSEcCtD
Indapamide—Pruritus—Conjugated Estrogens—osteoporosis	6.28e-05	0.000358	CcSEcCtD
Indapamide—Dyspepsia—Estradiol—osteoporosis	6.26e-05	0.000357	CcSEcCtD
Indapamide—CA12—Metabolism—P4HB—osteoporosis	6.24e-05	0.00114	CbGpPWpGaD
Indapamide—CA4—Metabolism—IDH2—osteoporosis	6.22e-05	0.00113	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.21e-05	0.00113	CbGpPWpGaD
Indapamide—Decreased appetite—Estradiol—osteoporosis	6.18e-05	0.000352	CcSEcCtD
Indapamide—Gastrointestinal disorder—Estradiol—osteoporosis	6.13e-05	0.00035	CcSEcCtD
Indapamide—Fatigue—Estradiol—osteoporosis	6.13e-05	0.000349	CcSEcCtD
Indapamide—CA12—Metabolism—GAPDH—osteoporosis	6.12e-05	0.00111	CbGpPWpGaD
Indapamide—Dizziness—Zoledronate—osteoporosis	6.1e-05	0.000348	CcSEcCtD
Indapamide—Pain—Estradiol—osteoporosis	6.08e-05	0.000346	CcSEcCtD
Indapamide—Constipation—Estradiol—osteoporosis	6.08e-05	0.000346	CcSEcCtD
Indapamide—Diarrhoea—Conjugated Estrogens—osteoporosis	6.08e-05	0.000346	CcSEcCtD
Indapamide—CA9—Metabolism—OXCT1—osteoporosis	6.07e-05	0.0011	CbGpPWpGaD
Indapamide—CA9—Metabolism—CA2—osteoporosis	6.07e-05	0.0011	CbGpPWpGaD
Indapamide—Nausea—Pamidronate—osteoporosis	6e-05	0.000342	CcSEcCtD
Indapamide—CA2—Metabolism—IDH2—osteoporosis	5.97e-05	0.00109	CbGpPWpGaD
Indapamide—CA12—Metabolism—RAP1A—osteoporosis	5.96e-05	0.00109	CbGpPWpGaD
Indapamide—CA9—Metabolism—MGLL—osteoporosis	5.91e-05	0.00108	CbGpPWpGaD
Indapamide—Dizziness—Conjugated Estrogens—osteoporosis	5.87e-05	0.000335	CcSEcCtD
Indapamide—Vomiting—Zoledronate—osteoporosis	5.86e-05	0.000334	CcSEcCtD
Indapamide—Feeling abnormal—Estradiol—osteoporosis	5.86e-05	0.000334	CcSEcCtD
Indapamide—CA4—Metabolism—CYP27A1—osteoporosis	5.85e-05	0.00107	CbGpPWpGaD
Indapamide—Rash—Zoledronate—osteoporosis	5.81e-05	0.000331	CcSEcCtD
Indapamide—Gastrointestinal pain—Estradiol—osteoporosis	5.81e-05	0.000331	CcSEcCtD
Indapamide—Dermatitis—Zoledronate—osteoporosis	5.81e-05	0.000331	CcSEcCtD
Indapamide—Headache—Zoledronate—osteoporosis	5.78e-05	0.000329	CcSEcCtD
Indapamide—CA4—Metabolism—ACP5—osteoporosis	5.69e-05	0.00104	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	5.68e-05	0.00103	CbGpPWpGaD
Indapamide—Vomiting—Conjugated Estrogens—osteoporosis	5.65e-05	0.000322	CcSEcCtD
Indapamide—Urticaria—Estradiol—osteoporosis	5.65e-05	0.000322	CcSEcCtD
Indapamide—Body temperature increased—Estradiol—osteoporosis	5.62e-05	0.00032	CcSEcCtD
Indapamide—Abdominal pain—Estradiol—osteoporosis	5.62e-05	0.00032	CcSEcCtD
Indapamide—CA2—Metabolism—CYP27A1—osteoporosis	5.61e-05	0.00102	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	5.6e-05	0.00102	CbGpPWpGaD
Indapamide—Rash—Conjugated Estrogens—osteoporosis	5.6e-05	0.000319	CcSEcCtD
Indapamide—Dermatitis—Conjugated Estrogens—osteoporosis	5.59e-05	0.000319	CcSEcCtD
Indapamide—CA5A—Metabolism—ENO1—osteoporosis	5.57e-05	0.00101	CbGpPWpGaD
Indapamide—Headache—Conjugated Estrogens—osteoporosis	5.56e-05	0.000317	CcSEcCtD
Indapamide—CA5A—Metabolism—PSMA5—osteoporosis	5.49e-05	0.001	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PSMA2—osteoporosis	5.49e-05	0.001	CbGpPWpGaD
Indapamide—Nausea—Zoledronate—osteoporosis	5.48e-05	0.000312	CcSEcCtD
Indapamide—CA2—Metabolism—ACP5—osteoporosis	5.46e-05	0.000993	CbGpPWpGaD
Indapamide—CA4—Metabolism—TPI1—osteoporosis	5.29e-05	0.000963	CbGpPWpGaD
Indapamide—Nausea—Conjugated Estrogens—osteoporosis	5.27e-05	0.000301	CcSEcCtD
Indapamide—Hypersensitivity—Estradiol—osteoporosis	5.24e-05	0.000298	CcSEcCtD
Indapamide—CA5B—Metabolism—ENO1—osteoporosis	5.2e-05	0.000947	CbGpPWpGaD
Indapamide—CA7—Metabolism—ENO1—osteoporosis	5.2e-05	0.000947	CbGpPWpGaD
Indapamide—CA7—Metabolism—PSMA2—osteoporosis	5.13e-05	0.000933	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PSMA2—osteoporosis	5.13e-05	0.000933	CbGpPWpGaD
Indapamide—CA7—Metabolism—PSMA5—osteoporosis	5.13e-05	0.000933	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PSMA5—osteoporosis	5.13e-05	0.000933	CbGpPWpGaD
Indapamide—Asthenia—Estradiol—osteoporosis	5.1e-05	0.000291	CcSEcCtD
Indapamide—CA2—Metabolism—TPI1—osteoporosis	5.07e-05	0.000923	CbGpPWpGaD
Indapamide—CA9—Metabolism—IDH2—osteoporosis	5.03e-05	0.000915	CbGpPWpGaD
Indapamide—Pruritus—Estradiol—osteoporosis	5.03e-05	0.000287	CcSEcCtD
Indapamide—CA4—Metabolism—P4HB—osteoporosis	4.97e-05	0.000906	CbGpPWpGaD
Indapamide—CA4—Metabolism—GAPDH—osteoporosis	4.88e-05	0.000889	CbGpPWpGaD
Indapamide—Diarrhoea—Estradiol—osteoporosis	4.86e-05	0.000277	CcSEcCtD
Indapamide—CA12—Metabolism—ENO1—osteoporosis	4.82e-05	0.000878	CbGpPWpGaD
Indapamide—CA2—Metabolism—P4HB—osteoporosis	4.77e-05	0.000868	CbGpPWpGaD
Indapamide—CA4—Metabolism—RAP1A—osteoporosis	4.76e-05	0.000866	CbGpPWpGaD
Indapamide—CA12—Metabolism—PSMA2—osteoporosis	4.75e-05	0.000865	CbGpPWpGaD
Indapamide—CA12—Metabolism—PSMA5—osteoporosis	4.75e-05	0.000865	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP27A1—osteoporosis	4.73e-05	0.000861	CbGpPWpGaD
Indapamide—Dizziness—Estradiol—osteoporosis	4.7e-05	0.000268	CcSEcCtD
Indapamide—CA2—Metabolism—GAPDH—osteoporosis	4.68e-05	0.000852	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	4.65e-05	0.000847	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.6e-05	0.000838	CbGpPWpGaD
Indapamide—CA9—Metabolism—ACP5—osteoporosis	4.6e-05	0.000837	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	4.59e-05	0.000836	CbGpPWpGaD
Indapamide—CA2—Metabolism—RAP1A—osteoporosis	4.56e-05	0.00083	CbGpPWpGaD
Indapamide—Vomiting—Estradiol—osteoporosis	4.52e-05	0.000258	CcSEcCtD
Indapamide—Rash—Estradiol—osteoporosis	4.48e-05	0.000255	CcSEcCtD
Indapamide—Dermatitis—Estradiol—osteoporosis	4.48e-05	0.000255	CcSEcCtD
Indapamide—CA5A—Metabolism—CYP19A1—osteoporosis	4.46e-05	0.000811	CbGpPWpGaD
Indapamide—Headache—Estradiol—osteoporosis	4.45e-05	0.000254	CcSEcCtD
Indapamide—CA9—Metabolism—TPI1—osteoporosis	4.28e-05	0.000778	CbGpPWpGaD
Indapamide—Nausea—Estradiol—osteoporosis	4.22e-05	0.000241	CcSEcCtD
Indapamide—CA7—Metabolism—CYP19A1—osteoporosis	4.16e-05	0.000757	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP19A1—osteoporosis	4.16e-05	0.000757	CbGpPWpGaD
Indapamide—CA9—Metabolism—P4HB—osteoporosis	4.02e-05	0.000732	CbGpPWpGaD
Indapamide—CA9—Metabolism—GAPDH—osteoporosis	3.95e-05	0.000718	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP19A1—osteoporosis	3.85e-05	0.000702	CbGpPWpGaD
Indapamide—CA4—Metabolism—ENO1—osteoporosis	3.84e-05	0.0007	CbGpPWpGaD
Indapamide—CA9—Metabolism—RAP1A—osteoporosis	3.84e-05	0.0007	CbGpPWpGaD
Indapamide—CA4—Metabolism—PSMA5—osteoporosis	3.79e-05	0.00069	CbGpPWpGaD
Indapamide—CA4—Metabolism—PSMA2—osteoporosis	3.79e-05	0.00069	CbGpPWpGaD
Indapamide—CA2—Metabolism—ENO1—osteoporosis	3.69e-05	0.000671	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ADCY5—osteoporosis	3.64e-05	0.000663	CbGpPWpGaD
Indapamide—CA2—Metabolism—PSMA5—osteoporosis	3.63e-05	0.000661	CbGpPWpGaD
Indapamide—CA2—Metabolism—PSMA2—osteoporosis	3.63e-05	0.000661	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GPX1—osteoporosis	3.63e-05	0.00066	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.41e-05	0.000621	CbGpPWpGaD
Indapamide—CA7—Metabolism—ADCY5—osteoporosis	3.4e-05	0.000619	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ADCY5—osteoporosis	3.4e-05	0.000619	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GPX1—osteoporosis	3.39e-05	0.000617	CbGpPWpGaD
Indapamide—CA7—Metabolism—GPX1—osteoporosis	3.39e-05	0.000617	CbGpPWpGaD
Indapamide—CA5A—Metabolism—MTHFR—osteoporosis	3.35e-05	0.00061	CbGpPWpGaD
Indapamide—CA12—Metabolism—ADCY5—osteoporosis	3.15e-05	0.000573	CbGpPWpGaD
Indapamide—CA12—Metabolism—GPX1—osteoporosis	3.14e-05	0.000571	CbGpPWpGaD
Indapamide—CA5B—Metabolism—MTHFR—osteoporosis	3.13e-05	0.000569	CbGpPWpGaD
Indapamide—CA7—Metabolism—MTHFR—osteoporosis	3.13e-05	0.000569	CbGpPWpGaD
Indapamide—CA9—Metabolism—ENO1—osteoporosis	3.11e-05	0.000565	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP19A1—osteoporosis	3.07e-05	0.000559	CbGpPWpGaD
Indapamide—CA9—Metabolism—PSMA5—osteoporosis	3.06e-05	0.000557	CbGpPWpGaD
Indapamide—CA9—Metabolism—PSMA2—osteoporosis	3.06e-05	0.000557	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP19A1—osteoporosis	2.95e-05	0.000536	CbGpPWpGaD
Indapamide—CA12—Metabolism—MTHFR—osteoporosis	2.9e-05	0.000527	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.77e-05	0.000503	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—IL6—osteoporosis	2.69e-05	0.00049	CbGpPWpGaD
Indapamide—CA5A—Metabolism—POMC—osteoporosis	2.68e-05	0.000487	CbGpPWpGaD
Indapamide—CA4—Metabolism—ADCY5—osteoporosis	2.51e-05	0.000457	CbGpPWpGaD
Indapamide—CA4—Metabolism—GPX1—osteoporosis	2.5e-05	0.000456	CbGpPWpGaD
Indapamide—CA5B—Metabolism—POMC—osteoporosis	2.5e-05	0.000455	CbGpPWpGaD
Indapamide—CA7—Metabolism—POMC—osteoporosis	2.5e-05	0.000455	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP19A1—osteoporosis	2.48e-05	0.000452	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.44e-05	0.000445	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.41e-05	0.000439	CbGpPWpGaD
Indapamide—CA2—Metabolism—ADCY5—osteoporosis	2.41e-05	0.000438	CbGpPWpGaD
Indapamide—CA2—Metabolism—GPX1—osteoporosis	2.4e-05	0.000437	CbGpPWpGaD
Indapamide—CA12—Metabolism—POMC—osteoporosis	2.32e-05	0.000422	CbGpPWpGaD
Indapamide—CA4—Metabolism—MTHFR—osteoporosis	2.31e-05	0.00042	CbGpPWpGaD
Indapamide—CA2—Metabolism—MTHFR—osteoporosis	2.21e-05	0.000403	CbGpPWpGaD
Indapamide—CA9—Metabolism—ADCY5—osteoporosis	2.03e-05	0.000369	CbGpPWpGaD
Indapamide—CA9—Metabolism—GPX1—osteoporosis	2.02e-05	0.000368	CbGpPWpGaD
Indapamide—CA9—Metabolism—MTHFR—osteoporosis	1.87e-05	0.00034	CbGpPWpGaD
Indapamide—CA4—Metabolism—POMC—osteoporosis	1.85e-05	0.000336	CbGpPWpGaD
Indapamide—CA2—Metabolism—POMC—osteoporosis	1.77e-05	0.000322	CbGpPWpGaD
Indapamide—CA9—Metabolism—POMC—osteoporosis	1.49e-05	0.000272	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—POMC—osteoporosis	1.47e-05	0.000267	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PKM—osteoporosis	1.39e-05	0.000252	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—FDPS—osteoporosis	1.39e-05	0.000252	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GPD2—osteoporosis	1.31e-05	0.000239	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PGLS—osteoporosis	1.31e-05	0.000239	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ATIC—osteoporosis	1.2e-05	0.000219	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PNP—osteoporosis	1.2e-05	0.000219	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—OXCT1—osteoporosis	1.02e-05	0.000186	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CA2—osteoporosis	1.02e-05	0.000186	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MGLL—osteoporosis	9.96e-06	0.000181	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—IDH2—osteoporosis	8.46e-06	0.000154	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP27A1—osteoporosis	7.96e-06	0.000145	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ACP5—osteoporosis	7.74e-06	0.000141	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TPI1—osteoporosis	7.2e-06	0.000131	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—P4HB—osteoporosis	6.77e-06	0.000123	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GAPDH—osteoporosis	6.64e-06	0.000121	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—RAP1A—osteoporosis	6.47e-06	0.000118	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ENO1—osteoporosis	5.23e-06	9.52e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PSMA2—osteoporosis	5.15e-06	9.38e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PSMA5—osteoporosis	5.15e-06	9.38e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.18e-06	7.61e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ADCY5—osteoporosis	3.42e-06	6.22e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GPX1—osteoporosis	3.4e-06	6.2e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MTHFR—osteoporosis	3.14e-06	5.72e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—POMC—osteoporosis	2.51e-06	4.57e-05	CbGpPWpGaD
